| Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ... The Lancet 381 (9860), 40-46, 2013 | 804 | 2013 |
| Role of anti-oxidants in atherosclerosis: epidemiological and clinical update A Cherubini, GB Vigna, G Zuliani, C Ruggiero, U Senin, R Fellin Current pharmaceutical design 11 (16), 2017-2032, 2005 | 196 | 2005 |
| Effect of a standardized grape seed extract on low-density lipoprotein susceptibility to oxidation in heavy smokers GB Vigna, F Costantini, G Aldini, M Carini, A Catapano, F Schena, ... Metabolism 52 (10), 1250-1257, 2003 | 184 | 2003 |
| Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia DJ Blom, MR Averna, EA Meagher, H du Toit Theron, CR Sirtori, ... Circulation 136 (3), 332-335, 2017 | 124 | 2017 |
| Lipids and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. GB Vigna, M Bolzan, F Romagnoni, G Valerio, E Vitale, G Zuliani, R Fellin Circulation 85 (6), 2205-2211, 1992 | 113 | 1992 |
| Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia D Noto, AB Cefalu, V Valenti, F Fayer, E Pinotti, M Ditta, R Spina, G Vigna, ... Arteriosclerosis, thrombosis, and vascular biology 32 (3), 805-809, 2012 | 95 | 2012 |
| Plasma lipoprotein composition, apolipoprotein (a) concentration and isoforms in β-thalassemia M Maioli, GB Vigna, G Tonolo, P Brizzi, M Ciccarese, P Donegà, M Maioli, ... Atherosclerosis 131 (1), 127-133, 1997 | 82 | 1997 |
| Spectrum of mutations in Italian patients with familial hypercholesterolemia: new results from the LIPIGEN study A Pirillo, K Garlaschelli, M Arca, M Averna, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 17-24, 2017 | 78 | 2017 |
| Efficacy of lomitapide in the treatment of familial homozygous hypercholesterolemia: results of a real-world clinical experience in Italy L D’Erasmo, AB Cefalù, D Noto, A Giammanco, M Averna, P Pintus, ... Advances in therapy 34, 1200-1210, 2017 | 77 | 2017 |
| Effect of age on the response of blood lipids, body composition, and aerobic power to physical conditioning and deconditioning F Giada, GB Vigna, E Vitale, G Baldo-Enzi, M Bertaglia, R Crecca, R Fellin Metabolism 44 (2), 161-165, 1995 | 77 | 1995 |
| Familial hypercholesterolemia: the Italian atherosclerosis society network (LIPIGEN) M Averna, AB Cefalu, M Casula, D Noto, M Arca, S Bertolini, S Calandra, ... Atherosclerosis Supplements 29, 11-16, 2017 | 74 | 2017 |
| Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD) PL Wood, VA Locke, P Herling, A Passaro, GB Vigna, S Volpato, ... BBA clinical 5, 25-28, 2016 | 73 | 2016 |
| Plasma lipoproteins in soy-treated postmenopausal women: a double-blind, placebo-controlled trial. GB Vigna, F Pansini, G Bonaccorsi, P Albertazzi, P Donega, L Zanotti, ... Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 10 (6), 315-322, 2000 | 70 | 2000 |
| Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society M Soresi, D Noto, AB Cefalu, S Martini, GB Vigna, M Fonda, E Manzato, ... Acta diabetologica 50, 241-249, 2013 | 68 | 2013 |
| Severe hypercholesterolaemia: unusual inheritance in an Italian pedigree G Zuliani, GB Vigna, A Corsini, M Maioli, F Romagnoni, R Fellin European journal of clinical investigation 25 (5), 322-331, 1995 | 63 | 1995 |
| Analbuminaemia: a natural model of metabolic compensatory systems G Baldo‐Enzi, MR Baiocchi, G Vigna, C Andrian, C Mosconi, R Fellin Journal of inherited metabolic disease 10 (4), 317-329, 1987 | 59 | 1987 |
| Bilateral strio-pallido-dentate calcinosis (Fahr’s disease): report of seven cases and revision of literature E Savino, C Soavi, E Capatti, M Borrelli, GB Vigna, A Passaro, G Zuliani BMC neurology 16, 1-11, 2016 | 58 | 2016 |
| Lipoprotein (a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study) S Volpato, GB Vigna, MM McDermott, M Cavalieri, C Maraldi, F Lauretani, ... The American journal of cardiology 105 (12), 1825-1830, 2010 | 57 | 2010 |
| Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study M Casula, E Olmastroni, A Pirillo, AL Catapano, M Arca, M Averna, ... Atherosclerosis 277, 413-418, 2018 | 51 | 2018 |
| Phase 3 HoFH Lomitapide Study investigators. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial … M Cuchel, EA Meagher, H du Toit Theron, DJ Blom, AD Marais, ... Lancet 381 (9860), 40-46, 2013 | 51 | 2013 |
